Pyrophosphate and Arterial Calcification in Chronic Kidney Disease
- Conditions
- Chronic Kidney Diseases
- Registration Number
- NCT04950439
- Lead Sponsor
- Centre Hospitalier Universitaire de Nice
- Brief Summary
Arterial calcifications start at early stages of chronic kidney disease (CKD) and are associated to cardiovascular mortality. Pyrophosphate (PPi) is an endogenous compound, which stops the mineralization process in bones and is expected to act at ectopic sites. In uremic rats, low PPi plasma levels are associated with high calcium content in the aorta and peritoneal administration of PPi blocks this process. People on maintenance dialysis or kidney transplant recipients have low plasma levels of PPi and show high scores of arterial calcification. The purpose is to determine the role of low PPi in the development of arterial calcifications in patients with CKD stage 3 or 4. To that aim, 252 patients with eGFR between 59 et 20 ml/min/1,73 m2 will be recruited and will be examined at baseline and three years later.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 242
- eGFR between 59 et 20 ml/min/1,73 m2 twice at three month interval
- kidney transplantation
- acute inflammatory disease or active cancer
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Plasma levels of PPI 3 years To show that low plasma levels of PPi at baseline is associated with a high progression of arterial calcification at three years after adjustment for confounding variables
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
CHU de Nice
🇫🇷Nice, Alpes Maritimes, France
CHU de Nice🇫🇷Nice, Alpes Maritimes, FranceFavre Guillaume, PhDPrincipal Investigator